“…The GABA A receptor is now accepted as a common target for many general anesthetics (Campagna, et al, 2003, Garrett and Gan, 1998, Hara and Harris, 2002, but enhanced GABAergic transmission is unlikely to modulate CSD susceptibility since barbiturates do not suppress CSD (Brand, et al, 1998, Kitahara, et al, 2001, Van Harreveld and Stamm, 1953. Relevant for CSD suppression, however, are the NMDA subtype of glutamate receptors, inhibition of which potently reduces CSD speed and duration, and blocks CSD (Gorelova, et al, 1987, Hernandez-Caceres, et al, 1987, Marrannes, et al, 1988, Obrenovitch and Zilkha, 1996. Interaction with NMDA receptors has thus far been convincingly demonstrated for isoflurane and N 2 O. Isoflurane causes modest inhibition of NMDA receptors, likely via the noncompetitive glycine site (Carla and Moroni, 1992, Dickinson, et al, 2007, Solt, et al, 2006.…”